AU1222799A - Antimalaria pharmaceutical compositions - Google Patents

Antimalaria pharmaceutical compositions

Info

Publication number
AU1222799A
AU1222799A AU12227/99A AU1222799A AU1222799A AU 1222799 A AU1222799 A AU 1222799A AU 12227/99 A AU12227/99 A AU 12227/99A AU 1222799 A AU1222799 A AU 1222799A AU 1222799 A AU1222799 A AU 1222799A
Authority
AU
Australia
Prior art keywords
antimalaria
pharmaceutical compositions
pharmaceutical
compositions
antimalaria pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12227/99A
Inventor
Guoqiao Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGZHOU KINCARE TECHNOLOGY CORP
Original Assignee
GUANGZHOU KINCARE TECHNOLOGY C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGZHOU KINCARE TECHNOLOGY C filed Critical GUANGZHOU KINCARE TECHNOLOGY C
Publication of AU1222799A publication Critical patent/AU1222799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU12227/99A 1997-11-18 1998-11-18 Antimalaria pharmaceutical compositions Abandoned AU1222799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN97114291A CN1081035C (en) 1997-11-18 1997-11-18 Antimalarial compound naphtholquine
CN97114291 1997-11-18
PCT/CN1998/000274 WO1999025351A1 (en) 1997-11-18 1998-11-18 Antimalaria pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU1222799A true AU1222799A (en) 1999-06-07

Family

ID=5172855

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12227/99A Abandoned AU1222799A (en) 1997-11-18 1998-11-18 Antimalaria pharmaceutical compositions

Country Status (6)

Country Link
CN (1) CN1081035C (en)
AU (1) AU1222799A (en)
CO (1) CO4980890A1 (en)
PE (1) PE134499A1 (en)
WO (1) WO1999025351A1 (en)
ZA (1) ZA9810472B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1135974C (en) * 2000-08-23 2004-01-28 重庆健桥医药开发有限公司 Antimalarial compound dihydroartemisinin
CN104666300B (en) * 2014-07-04 2017-01-18 昆药集团股份有限公司 Application of naphthoquine phosphate
CN111265527B (en) * 2020-03-05 2021-04-23 中国人民解放军军事科学院军事医学研究院 Application of naphthoquine and pharmaceutically acceptable salt thereof in preparation of anti-coronavirus medicines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748333A1 (en) * 1977-10-28 1979-05-03 Hoechst Ag AGENT AGAINST MALARIA
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
EP0362810B1 (en) * 1988-10-07 1993-05-05 Hoechst Aktiengesellschaft Antimalarial compositions using quinidine, artemisinine and its derivatives

Also Published As

Publication number Publication date
CO4980890A1 (en) 2000-11-27
PE134499A1 (en) 2000-01-23
CN1081035C (en) 2002-03-20
CN1191113A (en) 1998-08-26
WO1999025351A1 (en) 1999-05-27
ZA9810472B (en) 1999-05-21

Similar Documents

Publication Publication Date Title
AU6216296A (en) Pharmaceutical compositions
AU6740298A (en) Pharmaceutical composition
AU6513298A (en) Therapeutic compositions
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
GB9727053D0 (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU8591898A (en) Pharmaceutical compounds
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU5274096A (en) Pharmaceutical compositions
IL131995A0 (en) Gastric-retained pharmaceutical compositions
AU9343098A (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
ZA9811532B (en) Pharmaceutical compositions
AUPP332898A0 (en) Pharmaceutical composition
HU9700632D0 (en) Pharmaceutical compositions
AU4326197A (en) Pharmaceutical compositions
AUPN862596A0 (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AU1222799A (en) Antimalaria pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase